2-(Aryl-sulfonyl)oxetanes as designer 3-dimensional fragments for fragment screening: synthesis and strategies for functionalisation.

2-Sulfonyl-oxetanes have been prepared, affording non-planar structures with desirable physicochemical properties for fragment based drug discovery. The oxetane motif was formed by an intramolecular C-C bond formation. The fragments were further functionalised via organometallic intermediates at the intact oxetane and aromatic rings.

[1]  L. Pustilnik,et al.  Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors. , 2011, Journal of medicinal chemistry.

[2]  Monya Baker,et al.  Fragment-based lead discovery grows up , 2012, Nature Reviews Drug Discovery.

[3]  E. Carreira,et al.  Oxetanes as versatile elements in drug discovery and synthesis. , 2010, Angewandte Chemie.

[4]  O. A. Davis,et al.  Copper-catalyzed N-arylation of 2-imidazolines with aryl iodides. , 2013, The Journal of organic chemistry.

[5]  S. Matsunaga,et al.  Catalytic asymmetric synthesis of 2,2-disubstituted oxetanes from ketones by using a one-pot sequential addition of sulfur ylide. , 2009, Angewandte Chemie.

[6]  Christopher W Murray,et al.  Experiences in fragment-based drug discovery. , 2012, Trends in pharmacological sciences.

[7]  A. Nelson,et al.  Stereospecific conversion of (1R*,3S*)- and (1R*,3R*)-3-cyclohexyl-1-phenylpropane-1,3-diol into the corresponding 2,4-disubstituted oxetanes , 2000 .

[8]  Stephen D Pickett,et al.  The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types. , 2011, Drug discovery today.

[9]  M. Congreve,et al.  A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.

[10]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[11]  F. Chemla.  α-Oxy sulfones and sulfoximines: versatile intermediates , 2002 .

[12]  M. Hann,et al.  Finding the sweet spot: the role of nature and nurture in medicinal chemistry , 2012, Nature Reviews Drug Discovery.

[13]  Franz Schuler,et al.  Oxetanes in drug discovery: structural and synthetic insights. , 2010, Journal of medicinal chemistry.

[14]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[15]  E. Carreira,et al.  Oxetanes as promising modules in drug discovery. , 2006, Angewandte Chemie.

[16]  A. McPhail,et al.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.

[17]  F. Couty,et al.  2‐Cyanoazetidines and Azetidinium Ions: Scaffolds for Molecular Diversity , 2013 .

[18]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[19]  D. Scott,et al.  Fragment-based approaches in drug discovery and chemical biology. , 2012, Biochemistry.

[20]  P. Clemons,et al.  Route to three-dimensional fragments using diversity-oriented synthesis , 2011, Proceedings of the National Academy of Sciences.

[21]  Channa K. Hattotuwagama,et al.  Lead-oriented synthesis: a new opportunity for synthetic chemistry. , 2012, Angewandte Chemie.

[22]  F. Perna,et al.  2-Lithiated-2-phenyloxetane: a new attractive synthon for the preparation of oxetane derivatives. , 2011, Chemical communications.

[23]  M. Hann.  Molecular obesity, potency and other addictions in drug discovery , 2011 .

[24]  Andrew Pannifer,et al.  Using fragment-based technologies to target protein-protein interactions. , 2012, Current pharmaceutical design.

[25]  Yewen Fang,et al.  Preference of 4-exo ring closure in copper-catalyzed intramolecular coupling of vinyl bromides with alcohols. , 2007, Journal of the American Chemical Society.

[26]  Gerhard Klebe,et al.  A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes. , 2011, Journal of medicinal chemistry.

[27]  K. Okuma,et al.  Reaction of dimethyloxosulfonium methylide with epoxides. Preparation of oxetanes , 1983 .

[28]  A. Fürstner,et al.  Iron-Catalyzed Cross-Coupling Reactions of Alkyl-Grignard Reagents with Aryl Chlorides, Tosylates, and Triflates , 2002 .

[29]  Nathan E. Hnatiuk,et al.  Access to oxetane-containing psico-nucleosides from 2-methyleneoxetanes: a role for neighboring group participation? , 2011, The Journal of organic chemistry.

[30]  A. Capperucci,et al.  Stereoselective access to hydroxy oxetanes and tetrahydrooxepines through isomerization of oxiranyl ethers. , 2001, The Journal of organic chemistry.

[31]  S. Pickett,et al.  Increasing small molecule drug developability in sub-optimal chemical space , 2013 .

[32]  F. Perna,et al.  Exploiting the lithiation-directing ability of oxetane for the regioselective preparation of functionalized 2-aryloxetane scaffolds under mild conditions. , 2012, Angewandte Chemie.

[33]  A. Kinghorn,et al.  A hexacyclic ent-trachylobane diterpenoid possessing an oxetane ring from Mitrephora glabra. , 2005, Organic letters.

[34]  H. Perrier,et al.  Ortho-metalated aryl tert-butyl sulfones. Comparison with other directing groups and new methodology for polysubstituted aromatics , 1989 .

[35]  V. Snieckus,et al.  Selective ortho and benzylic functionalization of secondary and tertiary p-tolylsulfonamides. Ipso-bromo desilylation and Suzuki cross-coupling reactions. , 2001, The Journal of organic chemistry.

[36]  Y. Tanabe,et al.  Practical and efficient methods for sulfonylation of alcohols using Ts(Ms)Cl/Et3N and catalytic Me3H·HCl as combined base: Promising alternative to traditional pyridine , 1999 .

[37]  S. Buchwald,et al.  Catalysts for Suzuki-Miyaura coupling processes: scope and studies of the effect of ligand structure. , 2005, Journal of the American Chemical Society.

[38]  Beat Ernst,et al.  Drug discovery today. , 2003, Current topics in medicinal chemistry.

[39]  E. Carreira,et al.  Spirocyclic oxetanes: synthesis and properties. , 2008, Angewandte Chemie.

[40]  M. Abe.  Recent Progress Regarding Regio-, Site-, and Stereoselective Formation of Oxetanes in Paternò-Büchi Reactions , 2008 .

[41]  A. A. Fokin,et al.  Stereospecific consecutive epoxide ring expansion with dimethylsulfoxonium methylide. , 2010, The Journal of organic chemistry.

[42]  N. Shimada,et al.  Oxetanocin, a novel nucleoside from bacteria. , 1986, The Journal of antibiotics.